SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-16-560394
Filing Date
2016-04-28
Accepted
2016-04-27 20:59:12
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d177131dsc13d.htm SC 13D 54395
  Complete submission text file 0001193125-16-560394.txt   55762
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Subject) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-82674 | Film No.: 161596860
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 OFFICE CENTER DRIVE SUITE 400 FORT WASHINGTON PA 19034
Business Address 500 OFFICE CENTER DRIVE SUITE 400 FORT WASHINGTON PA 19034 949-725-4277
Madrigal Pharmaceuticals, Inc. (Filed by) CIK: 0001673226 (see all company filings)

IRS No.: 453050834 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D